28.05.2020 | COVID-19 | Letter to the Editors
Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse
Erschienen in: Journal of Neurology | Ausgabe 10/2020
Einloggen, um Zugang zu erhalten